SignalCorporate

CRISPR Therapeutics Announces Chief Financial Officer Transition

High-priority alert based on source significance and keyword relevance.

Context

What happened: CRISPR Therapeutics (Nasdaq: CRSP) said CFO Raju Prasad, Ph.D. is stepping down to pursue external opportunities, and A.J. Silver, Senior Vice President of Finance, succeeds him as CFO, effective today. Key numbers: Transition effective today, Oct. 19, 2026. Why it matters: CEO Samarth Kulkarni said Silver's eight years across the finance organization and knowledge of the business suit him to lead it. Kulkarni credited Prasad with strengthening the balance sheet and investment community relationships. Market: +1.6% today ($50.04), -6.9% YTD, 0.7x vol — as of 22:46 UTC

What changed

CRISPR Therapeutics (Nasdaq: CRSP) said CFO Raju Prasad, Ph.D. is stepping down to pursue external opportunities, and A.J. Silver, Senior Vice President of Finance, succeeds him as CFO, effective today.

Why it matters

CEO Samarth Kulkarni said Silver's eight years across the finance organization and knowledge of the business suit him to lead it. Kulkarni credited Prasad with strengthening the balance sheet and investment community relationships. Market: +1.6% today ($50.04), -6.9% YTD, 0.7x vol — as of 22:46 UTC

Sources

eodhd